Latest News in the pharma Industry

Top Stories

Human Genome Sciences Brands GSK Tender Offer 'Inadequate'

Human Genome Sciences Brands GSK Tender Offer 'Inadequate'

18 May 2012

HGS has urged stockholders not to tender their shares to GSK following the pharmaceutical giant's 'inadequate' tender offer.

Read more 
Breast Cancer Pipeline Remains Strong, Analysts Say

Breast Cancer Pipeline Remains Strong, Analysts Say

17 May 2012

A new report from Frost & Sullivan has highlighted the unmet need for breast cancer therapies.

Read more 
GSK to Fully Acquire Cellzome

GSK to Fully Acquire Cellzome

16 May 2012

GSK took an initial 19.98% stake in Cellzome in 2008 and will now purchase the remaining 80.02% shares in the company.

Read more 
IPEC Foundation to Establish IPEC India

IPEC Foundation to Establish IPEC India

15 May 2012

IPEC intends to play an instrumental role in sensitising the Indian excipient manufacturers and exporters about its guidelines which is globally accepted by top regulators across the world.

Read more 
Arena & Eisai Expand Lorcaserin Marketing & Supply Agreement

Arena & Eisai Expand Lorcaserin Marketing & Supply Agreement

14 May 2012

Arena and Eisai have announced an expansion to their original marketing and supply agreement for weight-loss drug candidate lorcaserin.

Read more 
Pharmaceuticals Industry Sees Spate of M&A Activity

Pharmaceuticals Industry Sees Spate of M&A Activity

14 May 2012

Some $33 billion of M&A activity took place among pharmaceuticals companies in April.

Read more 
GSK Commences Tender Offer to Acquire Human Genome Sciences

GSK Commences Tender Offer to Acquire Human Genome Sciences

14 May 2012

GSK has commenced an unsolicited tender offer to acquire all of the outstanding common shares of Human Genome Sciences at a price of $13 per share.

Read more 
AMRI Posts First Quarter 2012 Results

AMRI Posts First Quarter 2012 Results

10 May 2012

The company's total revenue for the first quarter of 2012 was $53.7 million, a decrease of 6% compared to total revenue of $56.9 million reported in the first quarter of 2011.

Read more 
BASF Acquires Equateq for Fatty Acids Portfolio

BASF Acquires Equateq for Fatty Acids Portfolio

10 May 2012

BASF says highly concentrated omega-3 fatty acids are a global growing market and increasing consumer awareness of the health benefits of omega-3 will see double-digit growth in the years to come.

Read more 
Bayer Yakuhin & Santen Enter Agreement for Eylea Injections

Bayer Yakuhin & Santen Enter Agreement for Eylea Injections

9 May 2012

Bayer Yakuhin and Santen will team up to promote Eylea in Japan.

Read more 
Affymetrix & eBioscience Amend Definitive Merger Agreement

Affymetrix & eBioscience Amend Definitive Merger Agreement

7 May 2012

Under the terms of the amended agreement, Affymetrix will acquire eBioscience for $315 million in cash subject to usual adjustments.

Read more 
NIH And Industry Team up to Find Uses for Abandoned Drugs

NIH And Industry Team up to Find Uses for Abandoned Drugs

7 May 2012

Pfizer, AstraZeneca and Lilly will make dozens of compounds available for the project.

Read more